首页|玻璃体切除术在增殖期糖尿病视网膜病变中的应用进展

玻璃体切除术在增殖期糖尿病视网膜病变中的应用进展

扫码查看
增殖期糖尿病视网膜病变(PDR)是糖尿病引起的一种复杂且危险的眼部并发症,常导致严重的视力受损.对于PDR患者,玻璃体切除术(PPV)是首选治疗方法,通过消除眼内新生血管(NV),纠正玻璃体积血(VH)和防止视网膜脱离(RD),从而维护患者的视觉功能和生活质量.近年来,随着微创玻璃体切割手术(MIVS)、广角观察系统(WAVS)、数字辅助可视化系统(DAS)、视网膜光凝术及抗血管内皮生长因子(VEGF)治疗等技术的不断发展和应用,PPV不仅明显改善PDR患者的视力,同时还能实现长期的解剖稳定性.因此,PPV成为糖尿病患者确切有效治疗的重要技术之一.本综述将对PDR中PPV的应用进行全面概述.
Application Progress of Pars Plana Vitrectomy in Proliferative Diabetic Retinopathy
Proliferative diabetic retinopathy(PDR)is a complex and dangerous ocular complication caused by diabetes mellitus,often resulting in severe visual impairment.For patients with PDR,pars plana vitrectomy(PPV)is the preferred treatment method to maintain the patient's visual function and quality of life by eliminating intraocular neovascularization(NH),correcting vitreous hemorrage(VH)and preventing retinal detachment(RD).In recent years,with the continuous development and application of minimally invasive pars plana vitrectomy(MIVS),wide-angle viewing system(WAVS),digital assistance system(DAS),retinal photocoagulation and anti-vascular endothelial growth factor(VEGF)therapies,PPV not only significantly improves the vision of PDR patients but also achieves long-term anatomical stability.Consequently,PPV has become one of the important techniques for the effective treatment of diabetic patients.This review will provide a comprehensive overview of the application of PPV in PDR.

Proliferative diabetic retinopathyPars plana vitrectomyVitreous hemorrhageRetinal detachment

王会艳、胡鹏、蒋丽娟、黄英

展开 >

邵阳学院附属第一医院 湖南 邵阳 422000

增殖期糖尿病视网膜病变 玻璃体切除术 玻璃体积血 视网膜脱离

湖南省科技创新计划项目

2020SK52105

2024

中外医学研究
中国医院管理杂志社

中外医学研究

影响因子:1.149
ISSN:1674-6805
年,卷(期):2024.22(18)